Differential effects of primary disease and corneal vascularisation on corneal transplant rejection and survival

Aims To investigate the relative risk of pretransplant corneal vascularisation on rate of rejection and graft failure within 5 years of surgery when categorised by indication for transplantation. We analysed all adults recorded in the UK transplant registry who had a first cornea transplant for keratoconus (KC), pseudophakic bullous keratopathy (PBK) or previous infection (viral/bacterial/fungal/protozoan) between 1999 and 2017. We analysed the number of quadrants of the recipient cornea vascularised before transplant and type of vascularisation, the interval post-transplant to rejection, if any, and the outcome at 5 years post-transplant. Risk factors for rejection and transplant failure were modelled by multivariable risk-adjusted Cox regression. Results Corneal vascularisation was recorded in 10%, 25% and 67% of patients with KC, PBK and infection, respectively. Individuals with PBK had an increased hazard of transplant rejection only when there were more than two quadrants of vascularisation (HR 1.5, p=0.004) when either superficial and/or deep vascularisation was present (HR 1.3 and 1.4, respectively, p=0.004). Individuals who had a transplant for previous infection had an increased hazard of rejection with four quadrants of vascularisation (HR 1.6, p=0.003). There was no risk-adjusted increase in transplant failure associated with vascularisation in any group. There was weak evidence of reduction in risk of rejection and/or failure associated with lamellar compared with penetrating transplantation in KC and PBK in vascularised recipient corneas. Conclusion Vascularisation is a risk factor for corneal allograft rejection within 5 years. The indication for transplantation has a clinically significant effect on the magnitude of this risk.

[1]  A. Penman,et al.  Effectiveness of Histocompatibility Matching in High-Risk Corneal Transplantation , 2020 .

[2]  D. Larkin,et al.  Longitudinal changes in corneal leucocyte density in vivo following transplantation , 2018, British Journal of Ophthalmology.

[3]  N. Gupta,et al.  Lymphatic vessels identified in failed corneal transplants with neovascularisation , 2018, British Journal of Ophthalmology.

[4]  T. Clahsen,et al.  Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival. , 2017, Investigative ophthalmology & visual science.

[5]  D. Larkin,et al.  The Influence of Donor and Recipient Gender Incompatibility on Corneal Transplant Rejection and Failure , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  R. Dana,et al.  Alloimmunity and Tolerance in Corneal Transplantation , 2016, The Journal of Immunology.

[7]  Gilles Thuret,et al.  Global Survey of Corneal Transplantation and Eye Banking. , 2016, JAMA ophthalmology.

[8]  Yalin Zheng,et al.  Angiographic and In Vivo Confocal Microscopic Characterization of Human Corneal Blood and Presumed Lymphatic Neovascularization: A Pilot Study , 2015, Cornea.

[9]  H. Dua,et al.  Clinical evaluation and characterisation of corneal vascularisation , 2015, British Journal of Ophthalmology.

[10]  Yalin Zheng,et al.  Corneal angiography for guiding and evaluating fine-needle diathermy treatment of corneal neovascularization. , 2015, Ophthalmology.

[11]  R. Dana,et al.  VEGF-trap Aflibercept Significantly Improves Long-term Graft Survival in High-risk Corneal Transplantation , 2015, Transplantation.

[12]  R. Dana,et al.  Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity , 2014, Journal of clinical & cellular immunology.

[13]  Yalin Zheng,et al.  Imaging and evaluation of corneal vascularization using fluorescein and indocyanine green angiography. , 2012, Investigative ophthalmology & visual science.

[14]  Don Yuen,et al.  Combined blockade of VEGFR-3 and VLA-1 markedly promotes high-risk corneal transplant survival. , 2011, Investigative ophthalmology & visual science.

[15]  D. Larkin,et al.  Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk. , 2010, American journal of ophthalmology.

[16]  Claus Cursiefen,et al.  Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. , 2010, Ophthalmology.

[17]  D. Larkin,et al.  Immune Privilege of Corneal Allografts , 2010, Ocular immunology and inflammation.

[18]  S. Wiegand,et al.  Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation , 2009, The Journal of Immunology.

[19]  F. Horn,et al.  GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. , 2009, Ophthalmology.

[20]  J. Ambati,et al.  Alternatively spliced VEGF receptor-2 is an essential endogenous inhibitor of lymphatic vessels , 2009, Nature Medicine.

[21]  D. Coster,et al.  Risk Factors for Human Corneal Graft Failure Within the Australian Corneal Graft Registry , 2008, Transplantation.

[22]  Y. Chan,et al.  Penetrating keratoplasty in Asian eyes: the Singapore Corneal Transplant Study. , 2008, Ophthalmology.

[23]  K. Maruyama,et al.  Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. , 2008, Archives of ophthalmology.

[24]  D. Sellami,et al.  Epidemiology and risk factors for corneal graft rejection. , 2007, Transplantation proceedings.

[25]  K. Maruyama,et al.  Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. , 2004, Investigative ophthalmology & visual science.

[26]  D F P Larkin,et al.  Corneal Transplantation: The Forgotten Graft , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[27]  Robert W. Thompson,et al.  Risk factors for various causes of failure in initial corneal grafts. , 2003, Archives of ophthalmology.

[28]  P. Wernet,et al.  HLA class I and II matching improves prognosis in penetrating normal-risk keratoplasty. , 2003, Developments in ophthalmology.

[29]  R. Dana,et al.  The critical role of lymph nodes in corneal alloimmunization and graft rejection. , 2001, Investigative ophthalmology & visual science.

[30]  S. Gore,et al.  Conclusions of the corneal transplant follow up study , 1997, The British journal of ophthalmology.

[31]  R. D. Stulting,et al.  Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. , 1994, Ophthalmology.

[32]  D. Roder,et al.  Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry. , 1992, Ophthalmology.

[33]  The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. , 1992, Archives of ophthalmology.

[34]  D. Coster,et al.  Leukocytes in the graft bed associated with corneal graft failure. Analysis by immunohistology and actuarial graft survival. , 1989, Ophthalmology.

[35]  D. Coster,et al.  Report from the Australian Corneal Graft Registry. , 1989, Transplantation proceedings.

[36]  S. I. Brown,et al.  A follow-up report on transplantation of the alkali-burned cornea. , 1974, American journal of ophthalmology.

[37]  G. Smolin,et al.  Lymphatic drainage from vascularized rabbit cornea. , 1971, American journal of ophthalmology.